Cargando…

Proposal of “cyclic therapy”, a novel treatment strategy with targeted agents for advanced renal cell carcinoma

The number of molecular targeted agents for advanced renal cell carcinoma (RCC) has gradually increased, but evidence on the optimal order of selection for such agents has not yet caught up with this trend. In addition, timing of switching molecular targeted drugs may also become an important issue...

Descripción completa

Detalles Bibliográficos
Autores principales: Nozawa, Masahiro, Uemura, Hirotsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708111/
https://www.ncbi.nlm.nih.gov/pubmed/26816747
http://dx.doi.org/10.3978/j.issn.2223-4683.2013.12.03